loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Eftrenonacog Alfa Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Sanofi

02 5Swedish Orphan Biovitrum AB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN

Brand Name : ALPROLIX

Dosage Form : KIT

Dosage Strength : 500UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2422913

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN

Brand Name : ALPROLIX

Dosage Form : KIT

Dosage Strength : 1000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2422921

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN

Brand Name : ALPROLIX

Dosage Form : KIT

Dosage Strength : 2000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2422948

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN

Brand Name : ALPROLIX

Dosage Form : KIT

Dosage Strength : 3000UNIT/VIAL

Packaging :

Approval Date :

Application Number : 2422956

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

05

Luxepack
Not Confirmed
arrow
arrow
Luxepack
Not Confirmed

Eftrenonacogum alfa

Brand Name : Alprolix

Dosage Form : Dry Sub

Dosage Strength : 1000iu

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

Luxepack
Not Confirmed
arrow
arrow
Luxepack
Not Confirmed

Eftrenonacogum alfa

Brand Name : Alprolix

Dosage Form : Dry Sub

Dosage Strength : 2000iu

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

Luxepack
Not Confirmed
arrow
arrow
Luxepack
Not Confirmed

Eftrenonacogum alfa

Brand Name : Alprolix

Dosage Form : Dry Sub

Dosage Strength : 250iu

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

Luxepack
Not Confirmed
arrow
arrow
Luxepack
Not Confirmed

Eftrenonacogum alfa

Brand Name : Alprolix

Dosage Form : Dry Sub

Dosage Strength : 3000iu

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

Luxepack
Not Confirmed
arrow
arrow
Luxepack
Not Confirmed

Eftrenonacogum alfa

Brand Name : Alprolix

Dosage Form : Dry Sub

Dosage Strength : 500iu

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank